Supplementary Methodology S1 from A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study

Key Points

MAIN FINDING: A novel combination of avelumab and chemotherapy is explored for resectable gastric cancer.
KEY EVIDENCE: The study evaluates the effectiveness of this treatment approach in a Phase II setting.
APPROACH: Participants included patients with resectable gastric cancer or gastroesophageal junction cancer receiving the therapy.
SIGNIFICANCE: This research could enhance treatment strategies for patients facing gastric cancer.

We only have this paper's title and publication details.

Phase II study examines combination of avelumab and chemotherapy in gastric cancer patients, suggesting potential treatment options.

Supplementary Methodology

No takes yet. Share an insight, caveat, or question.

Alsina et al. (2025) studied this question.

View at Publisher

Ask AI

Bookmark

Share